Heart BMJ

FEBRUARY 12, 2024

Pulmonary arterial hypertension related to congenital heart disease as a paradigm of complexity Pulmonary arterial hypertension related to congenital heart disease (PAH-CHD) really represents a paradigm of complexity.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Pulmonary Heart Disease 40

Circulation

NOVEMBER 11, 2024

Animal studies have shown that mice with TBX1 gene mutations have smaller left pulmonary arteries compared to wild type mice, defined by a reduced left pulmonary artery (LPA) to right pulmonary artery (RPA) ratio. A single study has shown this translates to humans with 22q11 and structurally normal hearts.

Pulmonary 40

Pulmonary Risk Factors Heart Disease Echocardiogram 40

Science Daily - Heart Disease

AUGUST 21, 2024

A new study has found that asporin, a protein encoded by the ASPN gene, plays a protective role in pulmonary arterial hypertension (PAH).

Pulmonary 108

Pulmonary Hypertension 108

Frontiers in Cardiovascular Medicine

MAY 8, 2024

Patients with pulmonary hypertension associated with a left-right shunt include a wide spectrum of pathophysiological substrates, ranging from those characterized by pulmonary over-circulation to those with advanced pulmonary vascular disease.

Congenital Heart Disease 52

Congenital Heart Disease Pulmonary Hypertension Congenital 52

Journal of the American Heart Association

SEPTEMBER 12, 2024

Due to improvements in recognition and management of their multisystem disease, the long‐term survival of infants, children, and adolescents with trisomy 21 and congenital heart disease now matches children with congenital heart disease and no genetic condition in many scenarios.

Congenital Heart Disease 66

Congenital Heart Disease Congenital Heart Disease Quality of Life 66

Journal of Cardiothoracic Surgery

MAY 10, 2024

Total anomalous pulmonary venous connection (TAPVC) is a rare congenital heart disease characterized by the inability of all pulmonary veins to connect to the left atrium. Our previous bibliometric article sum.

Pulmonary 52

Pulmonary Congenital Heart Disease Congenital Research 52

Journal of the American Heart Association

NOVEMBER 28, 2023

Transpulmonary exosomal miRs offer valuable insights into pulmonary circulation microenvironments. Using an in vitro flow model simulating the shear stress experienced by pulmonary endothelial cells, we observed a significant upregulation of miR‐21.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Pulmonary Heart Disease 40

Open Heart

DECEMBER 14, 2023

Objective To determine the magnitude of any excess risk of mortality and hospitalisation due to COVID-19 infection in patients with congenital heart disease (CHD) in the UK healthcare system. Of patients with a positive COVID-19 test, patients with CHD were more likely than controls to be hospitalised (22.4%

COVID-19 98

COVID-19 Congenital Heart Disease Congenital Heart Disease 98

Heart BMJ

FEBRUARY 12, 2024

Objective This study assessed the long-term effects of triple therapy with prostanoids on patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD), as there is limited information on the safety and efficacy of this treatment approach.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Pulmonary 40

Open Heart

SEPTEMBER 13, 2024

Background To determine the frequency of pregnancy complications and their association with the risk of cardiovascular outcomes in women with structural heart disease (SHD).

Heart Disease 52

Heart Disease Congenital Heart Disease Hypertension Congenital 52

Journal of Cardiothoracic Surgery

JANUARY 22, 2024

The left partial anomalous pulmonary vein connection is a rare congenital heart disease, especially with intact atrial septum. Now we reported a case of the left superior pulmonary vein drainage to left innomi.

Pulmonary 52

Pulmonary Congenital Heart Disease Congenital Heart Disease 52

Circulation

NOVEMBER 11, 2024

Neutrophil extracellular traps (NETs) may initiate the formation of PVTs, and NETs are associated with many diseases, such as type 2 diabetes mellitus (T2DM), atherosclerosis and heart diseases. Other NET-associated diseases might be ameliorated, so it is important to understand the traits of PVTs.We

Pulmonary 40

Pulmonary Diabetes Atherosclerosis Heart Disease 40

Frontiers in Cardiovascular Medicine

FEBRUARY 2, 2024

Aims A proportion of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) do not fit in the current classification.

Congenital Heart Disease 64

Congenital Heart Disease Congenital Pulmonary Hypertension 64

Circulation: Cardiovascular Interventions

NOVEMBER 6, 2023

Background:Neonates with complex congenital heart disease and pulmonary overcirculation have been historically treated surgically. Pulmonary arteries grew adequately for age, and devices were easily removed without complications. However, subcohorts may benefit from less invasive procedures. At a median follow-up of 6.2

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Pulmonary 40

Frontiers in Cardiovascular Medicine

JANUARY 14, 2024

Its use has been approved in the adult population with heart failure and described for pulmonary hypertension (PH). Only case reports and small series have been published about its use in the paediatric population and for congenital heart disease (CHD).

Congenital Heart Disease 59

Congenital Heart Disease Cardiomyopathy Congenital Heart Disease 59

Science Daily - Heart Disease

DECEMBER 13, 2023

Infusions of potentially therapeutic cells derived from the heart are safe for people with pulmonary arterial hypertension, a form of high blood pressure that occurs in the blood vessels of the lungs and typically affects middle-aged women, according to a new study.

Pulmonary 100

Pulmonary Hypertension Blood Pressure 100

Journal of the American Heart Association

NOVEMBER 28, 2023

Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. BackgroundLeft heart disease is the most common cause of pulmonary hypertension (PH) and is frequently accompanied by increases in pulmonary vascular resistance.

Pulmonary 40

Pulmonary Atrial Fibrillation Hypertension Heart Disease 40

Frontiers in Cardiovascular Medicine

JULY 5, 2024

IntroductionPrimary pulmonary vein stenosis (PVS) is a rare congenital heart disease that proves to be a clinical challenge due to the rapidly progressive disease course and high rates of treatment complications. These 3D reconstructions were 3D printed using a clear resin ink and used in a benchtop experimental setup.

Stenosis 52

Stenosis Pulmonary Congenital Heart Disease Stents 52

Frontiers in Cardiovascular Medicine

JANUARY 11, 2024

Objective Early risk assessment of pulmonary arterial hypertension (PAH) in patients with congenital heart disease (CHD) is crucial to ensure timely treatment. Class Activation Mapping (CAM) images demonstrated the model's attention focused on the pulmonary artery segment.

VSD 59

VSD Pulmonary Congenital Heart Disease Congenital 59

Journal of Cardiothoracic Surgery

FEBRUARY 5, 2024

Fallot-type absent pulmonary valve is a rare and complex congenital heart disease. Repair surgery for this condition during the neonatal period has a mortality rate of over 50%. We reported a neonate with Fall.

Congenital Heart Disease 40

Congenital Heart Disease Pulmonary Congenital Heart Disease 40

All About Cardiovascular System and Disorders

APRIL 8, 2024

Sudden breathlessness at night in those with known heart disease is usually due to collection of fluid in the lungs (pulmonary edema). Extra fluid in the body can occur due to failure of heart, kidneys, liver and rarely due to other causes.

Heart Disease 52

Heart Disease Bicuspid/Mitral Heart Failure Stenosis 52

American College of Cardiology

OCTOBER 31, 2024

Tetralogy of Fallot (TOF) is the most common form of cyanotic congenital heart disease (CHD). Early management of this condition is typically dictated by the degree of pulmonary stenosis (PS) and resulting oxygen saturations.

Congenital Heart Disease 59

Congenital Heart Disease Congenital Stenosis Pulmonary 59

The American Journal of Cardiology

JULY 9, 2024

Publication date: Available online 8 July 2024 Source: The American Journal of Cardiology Author(s): Emanuela Concetta D'Angelo, Gabriele Egidy Assenza, Anna Balducci, Ylenia Bartolacelli, Ambra Bulgarelli, Lucio Careddu, Cristina Ciuca, Elisabetta Mariucci, Luca Ragni, Andrea Donti, Gaetano Domenico Gargiulo, Emanuela Angeli

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Pulmonary 40

All About Cardiovascular System and Disorders

APRIL 17, 2024

Atrial septal defect – Ostium Primum, Ostium Secundum, Sinus Venosus Partial anomalous pulmonary venous return Atrioventricular septal defect Ventricular septal defect – inlet, outlet, perimembranous, muscular Patent ductus arteriosus Aortopulmonary window Coronary artery fistula draining to right heart Ruptured sinus of Valsalva aneurysm (..)

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease Aneurysm 52

HeartRhythm

JANUARY 29, 2024

Tetralogy of Fallot (TOF) is the most prevalent form of cyanotic congenital heart disease and has become the poster child for the evolution and success of neonatal cardiac surgery.

Pulmonary 40

Pulmonary Congenital Heart Disease Arrhythmia Congenital 40

All About Cardiovascular System and Disorders

FEBRUARY 14, 2024

Crochetage sign on ECG in ASD ECG in ASD with severe pulmonary hypertension: Tall R’ in V1, ST depression in inferior leads and V2-V5, and T inversion in inferior leads and V1-V6 are seen. All these features together in a cyanotic congenital heart disease is characteristic of tricuspid atresia.

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease VSD 52

Heart BMJ

DECEMBER 20, 2023

Objective Despite recent advances in surgical and interventional techniques, knowledge on the management of carcinoid heart disease (CHD) remains limited. Results Out of 43 (16%) consecutive patients with severe CHD and liver metastases of midgut NETs, 79% presented with right-sided heart failure.

Heart Disease 40

Heart Disease Tricuspid Outcomes Heart Failure 40

The American Journal of Cardiology

SEPTEMBER 3, 2024

Publication date: Available online 2 September 2024 Source: The American Journal of Cardiology Author(s): Alexandra C. van Dissel, Michele D'Alto, Andrea Farro, Harold Mathijssen, Marco C. Post, Pier P. Bassareo, Arie P.J. van Dijk, Barbara J.M. Mulder, Berto J.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Pulmonary 40

Frontiers in Cardiovascular Medicine

MAY 8, 2024

Pulmonary arterial hypertension (PAH) is a chronic and progressive disease that eventually leads to heart failure (HF) and subsequent fatality if left untreated. Right ventricular (RV) function has proven prognostic values in patients with a variety of heart diseases including PAH.

Pulmonary 40

Pulmonary Hypertension Heart Disease Article 40

Open Heart

JULY 17, 2023

Congenital heart disease (CHD) is likely to increase vulnerability and understanding the predictors of adverse outcomes is key to optimising care. to 1.10 (p<0.01)) and with pulmonary arterial hypertension (PAH; OR 5.99, 95% CI 1.34 to 7.97 (p=0.01)) and genetic disease (OR 2.87, 95% CI 1.04 to 26.91 (p=0.02)).

COVID-19 40

COVID-19 Congenital Heart Disease Congenital Heart Disease 40

Open Heart

JUNE 6, 2023

Objective Pulmonary hypertension (PHT) commonly coexists with significant mitral regurgitation (MR), but its prevalence and prognostic importance have not been well characterised. In a large cohort of adults with moderate or greater MR, we aimed to describe the prevalence and severity of PHT and assess its influence on outcomes.

Bicuspid/Mitral 52

Bicuspid/Mitral Pulmonary Hypertension Outcomes 52

HeartRhythm

AUGUST 31, 2024

The Cardiac and Lung E-cig Smoking Study (CLUES) evaluated acute differences in cardiovascular and pulmonary function among long-term ENDS users, long-term cigarette users, and control participants who never used either product. The long-term cardiovascular risks of electronic nicotine delivery systems (ENDS) use are unknown.

Heart Failure 40

Heart Failure Heart Disease Pulmonary 40

HeartRhythm

MARCH 12, 2024

A 37-year-old woman with biventricular repair for pulmonary atresia and an intact ventricular septum was referred for an electrophysiological study in the context of recurrent atrial arrhythmias with multiple electrical cardioversions. Her clinical tachycardia was easily inducible and had a cycle length (TCL) of 340 ms.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Electrophysiology 40

American College of Cardiology

DECEMBER 19, 2023

This year saw exciting developments in the treatment of pediatric and congenital heart disease. Transcatheter pulmonary valve replacement (TPVR) continued to dominate the field of interventional cardiology.

Congenital 70

Congenital Pediatrics Congenital Heart Disease Interventional Cardiology 70

Science Daily - Heart Disease

JANUARY 2, 2024

Higher levels of omega-3, the healthy fat found in fish and nuts, were associated with better lung function and longer transplant-free survival.

Pulmonary 103

Pulmonary Transplant 103

DAIC

JUNE 4, 2024

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment 5. Scientists Suggest a New Method for Diagnosing Heart Diseases 6. Weight Loss Drug Linked with Reduced Need for Diuretics in Heart Failure Patients 7. Tenax Therapeutics Announces New U.S.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Peripheral Arterial Disease Heart Failure Atrial Fibrillation 105

Frontiers in Cardiovascular Medicine

NOVEMBER 19, 2024

BackgroundWhile several studies have explored the outcomes of transcatheter interventions for modified Blalock–Taussig shunts (MBTSs) in a broad range of congenital heart diseases, none have specifically examined the interventions in patients with hypoplastic left heart syndrome (HLHS) who underwent Norwood palliation (NP).MethodsThis

Thrombosis 52

Thrombosis Stent Stents Congenital Heart Disease 52